<DOC>
	<DOCNO>NCT01601821</DOCNO>
	<brief_summary>To compare safety efficacy cyclosporine ( CsA ) + mycophenolate mofetil ( MMF ) + corticosteroid © CsA + Rapamune + Cs CsA elimination Rapamune arm introduction MMF de novo renal allograft recipient .</brief_summary>
	<brief_title>Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Age 13 year weight 40 kg Endstage renal disease , patient receive primary secondary renal allograft livingunrelated donor , livingrelated donor . Women childbearing potential must negative pregnancy test enrollment study agree use medically acceptable method contraception throughout treatment period 3 month follow discontinuation study . Total white blood cell count 4.0 x 109/L ( 4,000/mmP3P ) , platelet count 100 x 10P9P/L ( 100,000/mmP3P ) , fast triglyceride ≤ 4.6 mmol/L ( 400 mg/dL ) , fast cholesterol ≤ 7.8 mmol/L ( 300 mg/dL ) . If possible obtain fasting triglyceride cholesterol surgery , historical value ( within 1 year ) may use . Signed date informed consent ( parent legal guardian must provide consent patient &lt; 18 year age ) . An assent form sign patient &lt; 18 year age enrol study . Evidence active systemic localize major infection time initial Sirolimus administration . Cadaveric donor History malignancy within 5 year enrollment study ( exception adequately treat basal cell squamous cell carcinoma skin ) Use investigational drug specify protocol 4 week enrol study . Use plan antibody induction therapy time transplantation . Active gastrointestinal disorder may interfere drug absorption . Known hypersensitivity Sirolimus , MMF Cyclosporine derivative . Multiple organ transplant ( 2 organ transplant e.g . Kidney Pancreas ) . Patient high risk rejection ( eg . Patients PRA &gt; 50 % , black patient patient 2nd transplant lose first graft within first 6 month ) . Evidence infiltrate , cavitation , consolidation chest xray obtain prestudy screening</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>